Holen Sie sich die Stockscreener-App
3.41
4.48%
-0.16
Handel nachbörslich:
3.37
-0.04
-1.17%
Schlusskurs vom Vortag:
$3.57
Offen:
$3.63
24-Stunden-Volumen:
45,556
Relative Volume:
0.06
Marktkapitalisierung:
$7.78M
Einnahmen:
$75,700
Nettoeinkommen (Verlust:
$-7.23M
KGV:
-0.1982
EPS:
-17.2081
Netto-Cashflow:
$-7.37M
1W Leistung:
+10.71%
1M Leistung:
+4.28%
6M Leistung:
-55.42%
1J Leistung:
-68.48%
1-Tages-Spanne:
$3.37
$3.63
1-Wochen-Bereich:
$3.08
$3.63
52-Wochen-Spanne:
$2.3401
$12.03
Aclarion Inc Stock (ACON) Company Profile
Firmenname
Aclarion Inc
Sektor
Branche
Telefon
833 275 2266
Adresse
8181 ARISTA PLACE, BROOMFIELD
Compare ACON vs VEEV, TEM, BTSG, HQY, WAY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ACON
Aclarion Inc
|
3.41 | 8.15M | 75,700 | -7.23M | -7.37M | -17.21 |
VEEV
Veeva Systems Inc
|
174.64 | 28.42B | 3.20B | 908.91M | 1.39B | 5.4168 |
TEM
Tempus Ai Inc
|
47.30 | 8.47B | 1.27B | -245.03M | -245.36M | -1.4071 |
BTSG
Brightspring Health Services Inc
|
43.51 | 8.28B | 12.91B | 104.80M | 394.69M | 0.8769 |
HQY
Healthequity Inc
|
83.44 | 7.15B | 1.31B | 215.20M | 408.32M | 2.4627 |
WAY
Waystar Holding Corp
|
23.63 | 4.55B | 1.10B | 112.09M | 283.19M | 0.6096 |
Aclarion Inc Aktie (ACON) Neueste Nachrichten
Aclarion (NASDAQ: ACON) seeks stockholder approval to expand equity plan to 500,000 shares - Stock Titan
ACON Should I Buy - Intellectia AI
Aclarion Inc Stock Live Price, Chart, Analysis, News & Forecast – Buy, Sell & Trade US Equities Today - Mint
US Market Wrap: Will Aclarion Inc Equity Warrant outperform tech stocks2026 Big Picture & Daily Volume Surge Signals - baoquankhu1.vn
Is Aclarion Inc Equity Warrant stock a good dividend stock2026 Momentum & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Aug Macro: How does Aclarion Inc Equity Warrant correlate with Nasdaq2026 Growth vs Value & Fast Moving Stock Watchlists - baoquankhu1.vn
SEG Opportunity Fund (ACON) discloses 244,043 shares, 9.98% of Aclarion - Stock Titan
Aclarion (ACON): Analyst Lowers Price Target While Maintaining B - gurufocus.com
Macro Review: Should I hold or sell Aclarion Inc Equity Warrant now2026 Price Swings & Fast Moving Market Watchlists - baoquankhu1.vn
Echo Lake Capital Calls for the Resignation of David Neal From the Board of Directors of Aclarion Inc. - Bitget
Investment Review: Is Aclarion Inc. still a buy after recent gains2026 Review & Stepwise Trade Signal Guides - baoquankhu1.vn
Targets Report: Is Aclarion Inc still a buy after recent gainsPortfolio Update Summary & Scalable Portfolio Growth Ideas - baoquankhu1.vn
Aclarion, Inc. Adopts One-Year Stockholder Rights Plan to Protect Shareholder Value and Prevent Hostile Takeovers - Minichart
Aclarion adopts one-year stockholder rights plan By Investing.com - Investing.com India
Aclarion Adopts One-Year Stockholder Rights Protection Plan - TipRanks
Aclarion (NASDAQ: ACON) sets 10% trigger in one-year rights plan - Stock Titan
Aclarion adopts one-year stockholder rights plan - Investing.com
Aclarion, Inc. Adopts Limited Duration Stockholder Rights Plan - The Manila Times
Aclarion installs 1-year takeover defense, keeps door open to fair bids - Stock Titan
Shareholder Letter From Chief Executive Officer Brent Ness - 富途牛牛
Aclarion, Inc. Pursues Insurance Reimbursement Initiatives and Reports Strong Momentum Leading into 2026 - Quiver Quantitative
Aclarion Publishes CEO Shareholder Letter Highlighting Strategic Progress and 2026 Catalysts - Bluefield Daily Telegraph
Aclarion : Shareholder Letter from Chief Executive Officer Brent Ness - MarketScreener
Aclarion, Inc. Revolutionizes Low Back Pain Diagnosis with MR Spectroscopy and AI-Powered NOCISCAN Platform 798083 - Minichart
Published on: 2026-03-19 07:53:44 - baoquankhu1.vn
Aclarion (NASDAQ: ACON) expands NOCISCAN spine diagnostics and AI plans - Stock Titan
Aclarion 10-K: Revenue $0.076M, EPS (13.61) — Annual Report Highlights - tradingview.com
ACON: Revenue up 65.6% to $75.7K; net loss $7.2M; $22.6M raised in 2025, $10.4M in 2026 - tradingview.com
Aclarion, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Published on: 2026-03-19 06:54:42 - baoquankhu1.vn
Aclarion to Present at ROTH Conference, Showcasing Nociscan Technology for Chronic Back Pain Diagnosis - citybuzz -
Is Aclarion Inc Equity Warrant still a buy after recent gainsQuarterly Profit Report & Safe Entry Trade Reports - baoquankhu1.vn
Aclarion, Inc. to Engage with Investors at the 38th Annual ROTH Conference Regarding Nociscan Advancements - Quiver Quantitative
Aclarion to Participate in the 38th Annual ROTH Conference, Highlighting Key 2026 Catalysts and Strong Balance Sheet - Bitget
Back pain scan firm Aclarion meets investors at ROTH with no debt - Stock Titan
Investment Review: Whats the outlook for Aclarion Inc Equity Warrants sectorWeekly Market Summary & Daily Technical Stock Forecast Reports - baoquankhu1.vn
Aug Shorts: Is Aclarion Inc Equity Warrant benefiting from interest rate changes2026 Technical Overview & Consistent Profit Alerts - baoquankhu1.vn
Aclarion CEO to Present AI-Powered Back Pain Diagnostic Technology at Leading MedTech Conference - citybuzz -
Aclarion CEO Brent Ness to Attend LSI USA 2026 - Bitget
Aclarion, Inc. CEO Brent Ness to Attend LSI USA 2026 to Discuss NOCISCAN and Industry Partnerships - Quiver Quantitative
Back pain imaging firm Aclarion courts partners at LSI USA 2026 - Stock Titan
Quarterly Risk: Is Aclarion Inc Equity Warrant stock undervalued right nowQuarterly Profit Review & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Decliners Report: Is Aclarion Inc Equity Warrant attractive for institutional investorsTrade Volume Report & Growth-Oriented Investment Plans - baoquankhu1.vn
What is Aclarion Inc Equity Warrants 5 year growth outlookJuly 2025 Spike Watch & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Will Aclarion Inc. stock benefit from upcoming earnings reports2026 Chart Watch & Proven Capital Preservation Methods - Naître et grandir
Aug EndMonth: How Aclarion Inc. Equity Warrant stock reacts to job market dataTrade Analysis Report & Accurate Buy Signal Notifications - Naître et grandir
Dividend Watch: Will Aclarion Inc Equity Warrant outperform during market rallies2025 Analyst Calls & Breakout Confirmation Alerts - baoquankhu1.vn
Analyst Calls: Will Aclarion Inc Equity Warrant outperform during market ralliesIndex Update & Consistent Return Strategy Ideas - baoquankhu1.vn
Bank Watch: Does Five Below Inc stock have upside surprise potentialMarket Activity Recap & Safe Entry Momentum Tips - baoquankhu1.vn
Retail Trends: Whats next for CalciMedica Inc stock2025 Sector Review & Technical Entry and Exit Tips - baoquankhu1.vn
ACON PE Ratio & Valuation, Is ACON Overvalued - Intellectia AI
Finanzdaten der Aclarion Inc-Aktie (ACON)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.79%
1.97%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):